• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析透明细胞肾细胞癌的肿瘤微环境:基于机器学习的程序性死亡基因的预后见解。

Deciphering the tumour microenvironment of clear cell renal cell carcinoma: Prognostic insights from programmed death genes using machine learning.

机构信息

Department of Urology, Dazhou Central Hospital, Dazhou, Sichuan, China.

School of Clinical Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, China.

出版信息

J Cell Mol Med. 2024 Jul;28(13):e18524. doi: 10.1111/jcmm.18524.

DOI:10.1111/jcmm.18524
PMID:39011666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11249822/
Abstract

Clear cell renal cell carcinoma (ccRCC), a prevalent kidney cancer form characterised by its invasiveness and heterogeneity, presents challenges in late-stage prognosis and treatment outcomes. Programmed cell death mechanisms, crucial in eliminating cancer cells, offer substantial insights into malignant tumour diagnosis, treatment and prognosis. This study aims to provide a model based on 15 types of Programmed Cell Death-Related Genes (PCDRGs) for evaluating immune microenvironment and prognosis in ccRCC patients. ccRCC patients from the TCGA and arrayexpress cohorts were grouped based on PCDRGs. A combination model using Lasso and SuperPC was constructed to identify prognostic gene features. The arrayexpress cohort validated the model, confirming its robustness. Immune microenvironment analysis, facilitated by PCDRGs, employed various methods, including CIBERSORT. Drug sensitivity analysis guided clinical treatment decisions. Single-cell data enabled Programmed Cell Death-Related scoring, subsequent pseudo-temporal and cell-cell communication analyses. A PCDRGs signature was established using TCGA-KIRC data. External validation in the arrayexpress cohort underscored the model's superiority over traditional clinical features. Furthermore, our single-cell analysis unveiled the roles of PCDRG-based single-cell subgroups in ccRCC, both in pseudo-temporal progression and intercellular communication. Finally, we performed CCK-8 assay and other experiments to investigate csf2. In conclusion, these findings reveal that csf2 inhibit the growth, infiltration and movement of cells associated with renal clear cell carcinoma. This study introduces a PCDRGs prognostic model benefiting ccRCC patients while shedding light on the pivotal role of programmed cell death genes in shaping the immune microenvironment of ccRCC patients.

摘要

透明细胞肾细胞癌 (ccRCC) 是一种常见的肾癌形式,其特点是侵袭性和异质性,在晚期预后和治疗结果方面带来挑战。程序性细胞死亡机制在消除癌细胞方面至关重要,为恶性肿瘤的诊断、治疗和预后提供了重要的见解。本研究旨在基于 15 种程序性细胞死亡相关基因 (PCDRGs) 为 ccRCC 患者建立一个评估免疫微环境和预后的模型。根据 PCDRGs 将 TCGA 和 arrayexpress 队列中的 ccRCC 患者进行分组。使用 Lasso 和 SuperPC 构建组合模型,以识别预后基因特征。arrayexpress 队列验证了该模型,证实了其稳健性。通过 PCDRGs 进行免疫微环境分析,采用了包括 CIBERSORT 在内的各种方法。药物敏感性分析指导临床治疗决策。单细胞数据可进行程序性细胞死亡相关评分,随后进行伪时间和细胞间通讯分析。使用 TCGA-KIRC 数据建立 PCDRGs 特征。在 arrayexpress 队列中的外部验证突显了该模型优于传统临床特征的优势。此外,我们的单细胞分析揭示了基于 PCDRG 的单细胞亚群在 ccRCC 中的作用,包括伪时间进展和细胞间通讯。最后,我们进行了 CCK-8 测定和其他实验来研究 csf2。总之,这些发现表明 csf2 抑制与肾透明细胞癌相关的细胞的生长、浸润和运动。本研究介绍了一个 PCDRGs 预后模型,使 ccRCC 患者受益,同时揭示了程序性细胞死亡基因在塑造 ccRCC 患者免疫微环境中的关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/4552b99fbf96/JCMM-28-e18524-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/217cd6ce7bdd/JCMM-28-e18524-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/07e4fc23e808/JCMM-28-e18524-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/aada904122c1/JCMM-28-e18524-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/7898a319e185/JCMM-28-e18524-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/774608176a56/JCMM-28-e18524-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/1dbf12a13a48/JCMM-28-e18524-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/651e043479fa/JCMM-28-e18524-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/33f43cafb151/JCMM-28-e18524-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/40997d0bee17/JCMM-28-e18524-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/3be97eea12d5/JCMM-28-e18524-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/157620ea6c3e/JCMM-28-e18524-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/4552b99fbf96/JCMM-28-e18524-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/217cd6ce7bdd/JCMM-28-e18524-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/07e4fc23e808/JCMM-28-e18524-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/aada904122c1/JCMM-28-e18524-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/7898a319e185/JCMM-28-e18524-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/774608176a56/JCMM-28-e18524-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/1dbf12a13a48/JCMM-28-e18524-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/651e043479fa/JCMM-28-e18524-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/33f43cafb151/JCMM-28-e18524-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/40997d0bee17/JCMM-28-e18524-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/3be97eea12d5/JCMM-28-e18524-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/157620ea6c3e/JCMM-28-e18524-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0b4/11249822/4552b99fbf96/JCMM-28-e18524-g012.jpg

相似文献

1
Deciphering the tumour microenvironment of clear cell renal cell carcinoma: Prognostic insights from programmed death genes using machine learning.解析透明细胞肾细胞癌的肿瘤微环境:基于机器学习的程序性死亡基因的预后见解。
J Cell Mol Med. 2024 Jul;28(13):e18524. doi: 10.1111/jcmm.18524.
2
A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma.一种基于液-液相分离相关基因的新型风险特征揭示了透明细胞肾细胞癌的预后及肿瘤微环境特征。
Aging (Albany NY). 2024 Mar 27;16(7):6118-6134. doi: 10.18632/aging.205691.
3
Unravelling infiltrating T-cell heterogeneity in kidney renal clear cell carcinoma: Integrative single-cell and spatial transcriptomic profiling.解析肾透明细胞癌浸润性 T 细胞异质性:整合单细胞和空间转录组分析。
J Cell Mol Med. 2024 Jun;28(12):e18403. doi: 10.1111/jcmm.18403.
4
Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma.解析透明细胞肾细胞癌中恶性肿瘤和肿瘤微环境的谷氨酰胺代谢模式。
Clin Exp Med. 2024 Jul 6;24(1):152. doi: 10.1007/s10238-024-01390-4.
5
Anoikis resistance regulates immune infiltration and drug sensitivity in clear-cell renal cell carcinoma: insights from multi omics, single cell analysis and experiment.失巢凋亡抵抗调节透明细胞肾细胞癌中的免疫浸润和药物敏感性:多组学、单细胞分析和实验的见解。
Front Immunol. 2024 Jun 17;15:1427475. doi: 10.3389/fimmu.2024.1427475. eCollection 2024.
6
Exosome-related lncRNA score: A value-based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma.外泌体相关长链非编码 RNA 评分:一种基于价值的个体化治疗策略,用于预测透明细胞肾细胞癌对免疫治疗的反应。
Cancer Med. 2024 Jun;13(11):e7308. doi: 10.1002/cam4.7308.
7
Identification of HDAC10 as a candidate oncogene in clear cell renal carcinoma that facilitates tumor proliferation and metastasis.鉴定 HDAC10 为透明细胞肾细胞癌的候选癌基因,促进肿瘤增殖和转移。
Diagn Pathol. 2024 Sep 5;19(1):120. doi: 10.1186/s13000-024-01493-2.
8
Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.大规模转录组谱揭示了强大的 20 个特征代谢预测模型和 G6PC 在透明细胞肾细胞癌中的新作用。
J Cell Mol Med. 2020 Aug;24(16):9012-9027. doi: 10.1111/jcmm.15536. Epub 2020 Jun 21.
9
Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.构建具有预后意义的新型免疫相关 lncRNA 对用于肾透明细胞肾细胞癌。
Dis Markers. 2021 Sep 1;2021:8800358. doi: 10.1155/2021/8800358. eCollection 2021.
10
Comprehensive investigation of malignant epithelial cell-related genes in clear cell renal cell carcinoma: development of a prognostic signature and exploration of tumor microenvironment interactions.全面研究透明细胞肾细胞癌中恶性上皮细胞相关基因:预后标志物的开发及肿瘤微环境相互作用的探索。
J Transl Med. 2024 Jul 1;22(1):607. doi: 10.1186/s12967-024-05426-x.

引用本文的文献

1
Integrative single-cell and spatial transcriptomics uncover ELK4-mediated mechanisms in + tumor cells driving gastric cancer progression, metabolic reprogramming, and immune evasion.整合单细胞和空间转录组学揭示ELK4介导的肿瘤细胞驱动胃癌进展、代谢重编程和免疫逃逸的机制。
Front Immunol. 2025 Jul 4;16:1591123. doi: 10.3389/fimmu.2025.1591123. eCollection 2025.
2
TSPAN4 fibroblasts coordinate metastatic niche assembly through migrasome-driven metabolic reprogramming and stromal-immune crosstalk in pancreatic adenocarcinoma.TSPAN4 成纤维细胞通过迁移体驱动的代谢重编程和胰腺腺癌中的基质 - 免疫串扰来协调转移微环境的组装。
Front Immunol. 2025 May 15;16:1594879. doi: 10.3389/fimmu.2025.1594879. eCollection 2025.
3

本文引用的文献

1
Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer.褪黑素及其在癌症上皮-间质转化(EMT)中的作用
Cancers (Basel). 2024 Feb 27;16(5):956. doi: 10.3390/cancers16050956.
2
Elucidating the Influence of MPT-driven necrosis-linked LncRNAs on immunotherapy outcomes, sensitivity to chemotherapy, and mechanisms of cell death in clear cell renal carcinoma.阐明线粒体通透性转换(MPT)驱动的坏死相关长链非编码RNA(lncRNAs)对透明细胞肾细胞癌免疫治疗结果、化疗敏感性及细胞死亡机制的影响。
Front Oncol. 2023 Dec 15;13:1276715. doi: 10.3389/fonc.2023.1276715. eCollection 2023.
3
Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms.
Elucidating stearoyl metabolism and NCOA4-mediated ferroptosis in gastric cancer liver metastasis through multi-omics single-cell integrative mendelian analysis: advancing personalized immunotherapy strategies.
通过多组学单细胞整合孟德尔分析阐明胃癌肝转移中的硬脂酰代谢和NCOA4介导的铁死亡:推进个性化免疫治疗策略
Discov Oncol. 2025 Jan 15;16(1):46. doi: 10.1007/s12672-025-01769-z.
4
Single-cell transcriptomics reveals heterogeneity and prognostic markers of myeloid precursor cells in acute myeloid leukemia.单细胞转录组学揭示急性髓系白血病中髓系前体细胞的异质性和预后标志物。
Front Immunol. 2024 Dec 16;15:1494106. doi: 10.3389/fimmu.2024.1494106. eCollection 2024.
5
The role of KRT18 in lung adenocarcinoma development: integrative bioinformatics and experimental validation.KRT18在肺腺癌发生发展中的作用:综合生物信息学与实验验证
Discov Oncol. 2024 Dec 27;15(1):841. doi: 10.1007/s12672-024-01728-0.
6
Exploring the role of Disulfidptosis in glioma progression: insights into tumor heterogeneity and therapeutic potential through single-cell RNA sequencing.探索二硫化物诱导细胞程序性坏死在胶质瘤进展中的作用:通过单细胞RNA测序洞察肿瘤异质性和治疗潜力
Discov Oncol. 2024 Dec 23;15(1):829. doi: 10.1007/s12672-024-01685-8.
7
Integrating multi-omics techniques and experiments reveals that GLRX3 regulates the immune microenvironment and promotes hepatocellular carcinoma cell proliferation and invasion through iron metabolism pathways.整合多组学技术和实验表明,GLRX3通过铁代谢途径调节免疫微环境并促进肝癌细胞增殖和侵袭。
Front Immunol. 2024 Nov 25;15:1496886. doi: 10.3389/fimmu.2024.1496886. eCollection 2024.
8
Exploring copper metabolism-induced cell death in gastric cancer: a single-cell RNA sequencing study and prognostic model development.探索铜代谢诱导的胃癌细胞死亡:一项单细胞RNA测序研究及预后模型开发
Discov Oncol. 2024 Sep 27;15(1):482. doi: 10.1007/s12672-024-01374-6.
揭示二硫化物诱导细胞焦亡相关长链非编码RNA在结肠癌中的作用:免疫治疗反应、化疗敏感性的预后指标及对细胞死亡机制的见解
Front Mol Biosci. 2023 Oct 17;10:1254232. doi: 10.3389/fmolb.2023.1254232. eCollection 2023.
4
Identification of RNA-binding protein YBX3 as an oncogene in clear cell renal cell carcinoma.鉴定 RNA 结合蛋白 YBX3 为透明细胞肾细胞癌的致癌基因。
Funct Integr Genomics. 2023 Jul 7;23(3):225. doi: 10.1007/s10142-023-01145-6.
5
A novel 7-chemokine-genes predictive signature for prognosis and therapeutic response in renal clear cell carcinoma.一种用于预测肾透明细胞癌预后和治疗反应的新型7-趋化因子基因特征。
Front Pharmacol. 2023 Mar 20;14:1120562. doi: 10.3389/fphar.2023.1120562. eCollection 2023.
6
Cell Differentiation Trajectory Predicts Prognosis and Immunotherapeutic Response in Clear Cell Renal Cell Carcinoma.细胞分化轨迹可预测透明细胞肾细胞癌的预后和免疫治疗反应。
Genet Res (Camb). 2022 Nov 29;2022:8422339. doi: 10.1155/2022/8422339. eCollection 2022.
7
Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes.头颈部鳞状细胞癌中神经营养因子相关基因特征的鉴定与验证,以预测生存和免疫格局。
Front Genet. 2022 Nov 4;13:1010044. doi: 10.3389/fgene.2022.1010044. eCollection 2022.
8
Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.坏死性凋亡和焦亡的串扰定义了肿瘤微环境特征,并预测了透明细胞肾细胞癌的预后。
Front Immunol. 2022 Sep 30;13:1021935. doi: 10.3389/fimmu.2022.1021935. eCollection 2022.
9
Cuproptosis-related gene expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma.铜死亡相关基因表达与透明细胞肾细胞癌的预后和肿瘤免疫微环境相关。
Front Immunol. 2022 Sep 26;13:999823. doi: 10.3389/fimmu.2022.999823. eCollection 2022.
10
Comprehensive pan-cancer analysis identifies cellular senescence as a new therapeutic target for cancer: multi-omics analysis and single-cell sequencing validation.全面的泛癌分析将细胞衰老确定为癌症的新治疗靶点:多组学分析和单细胞测序验证。
Am J Cancer Res. 2022 Sep 15;12(9):4103-4119. eCollection 2022.